GPT and melanoma: Of note, a high rate of treatment-related alanine aminotransferase increase (31.3%) was also observed in the phase 2 POLARIS-01 study, which investigated the PD-1 inhibitor toripalimab in 128 Chinese patients with advanced melanoma previously treated with systemic therapy (10).